Anavex Life Sciences Corp.
AVXL
$2.75
-$0.10-3.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.96% | 10.06% | 9.09% | -22.40% | -27.09% |
| Total Receivables | 21.34% | 39.94% | -66.99% | -66.97% | -52.33% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 82.59% | -41.31% | -44.30% | -53.92% | -57.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.29% | 9.93% | 7.21% | -23.42% | -27.63% |
|
|
|||||
| Total Current Assets | 17.29% | 9.93% | 7.21% | -23.42% | -27.63% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 17.29% | 9.93% | 7.21% | -23.42% | -27.63% |
|
|
|||||
| Total Accounts Payable | -45.76% | -63.98% | -42.22% | -55.86% | 92.41% |
| Total Accrued Expenses | 2.72% | -60.92% | -62.14% | -21.25% | -46.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -2.90% | -2.90% | -5.08% | -12.21% |
| Total Other Current Liabilities | -- | -2.90% | -2.90% | -5.08% | -12.21% |
| Total Current Liabilities | -32.96% | -59.39% | -51.47% | -41.54% | -2.38% |
|
|
|||||
| Total Current Liabilities | -32.96% | -59.39% | -51.47% | -41.54% | -2.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -32.96% | -59.39% | -51.47% | -41.54% | -2.38% |
|
|
|||||
| Common Stock & APIC | 7.44% | 12.21% | 12.12% | 4.60% | 2.04% |
| Retained Earnings | -3.49% | -9.49% | -11.47% | -13.80% | -14.85% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 23.63% | 22.00% | 14.16% | -21.12% | -29.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.63% | 22.00% | 14.16% | -21.12% | -29.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.63% | 22.00% | 14.16% | -21.12% | -29.91% |
|
|
|||||